Deciphering the Inflammatory Response in Colorectal and Ovarian Cancers
Researchers are focusing on the inflammatory response in colorectal and ovarian cancers to understand its role in tumor progression. The goal is to identify specific inflammatory pathways and develop targeted therapies for these cancers, which are among the most prevalent and lethal globally.
Colorectal cancer is the third most prevalent malignancy worldwide and is linked to chronic inflammatory bowel diseases. The tumor microenvironment in colorectal cancer is populated by diverse immune cells. Ovarian cancer is often diagnosed at advanced stages, with inflammation playing a crucial role in its progression. Researchers aim to identify specific inflammatory pathways and develop targeted therapies. Recent studies highlight the need to understand the immune mechanisms involved. By leveraging advances in single-cell sequencing and artificial intelligence, researchers seek to identify targetable pathways and develop personalized therapeutic strategies.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.